Inhibition of Pyk2, either pharmacologically using Pyk2/FAK inhibitor PF-562,271 (13 nM) or via siRNA-mediated knockdown, effectively blocked microglia-induced glioma cell migration. Here, PTK2B is linked to central nervous system cancer.